UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 483

Sortiert nach

Does A Kinematically Aligned Total Knee Arthroplasty Restore Function Without Failure Regardless of Alignment Category?

Clinical orthopaedics and related research, 2013-03, Vol.471 (3), p.1000-1007

2013

Volltextzugriff (PDF)

Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy

PLoS neglected tropical diseases, 2016-02, Vol.10 (2), p.e0004423-e0004423

2016

Volltextzugriff (PDF)

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5–17 months in Kenya and Tanzania: a randomised controlled trial

The Lancet infectious diseases, 2011-02, Vol.11 (2), p.102-109

2011

Volltextzugriff (PDF)

Molecular Basis of Allele-Specific Efficacy of a Blood-Stage Malaria Vaccine: Vaccine Development Implications

The Journal of infectious diseases, 2013-02, Vol.207 (3), p.511-519

2013

Volltextzugriff (PDF)

Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial

PloS one, 2009-11, Vol.4 (11), p.e7849-e7849

2009

Volltextzugriff (PDF)

Update on the clinical development of candidate malaria vaccines

The American journal of tropical medicine and hygiene, 2004-08, Vol.71 (2 Suppl), p.239

2004

Volltextzugriff (PDF)

Malaria vaccine development: Trials, tribulations and reasons for hope

Human vaccines, 2009-01, Vol.5 (1), p.2-5

Cohen, Joe

2009

Volltextzugriff (PDF)

Evaluation of the Safety and Immunogenicity of Two Antigen Concentrations of the Mtb72F/AS02A Candidate Tuberculosis Vaccine in Purified Protein Derivative-Negative Adults

Clinical and Vaccine Immunology, 2010-11, Vol.17 (11), p.1763-1771

2010

Volltextzugriff (PDF)

Priming with an Adenovirus 35-Circumsporozoite Protein (CS) Vaccine followed by RTS,S/AS01B Boosting Significantly Improves Immunogenicity to Plasmodium falciparum CS Compared to That with Either Malaria Vaccine Alone

Infection and Immunity, 2007-05, Vol.75 (5), p.2283-2290

2007

Volltextzugriff (PDF)

Induction in Humans of CD8+ and CD4+ T Cell and Antibody Responses by Sequential Immunization with Malaria DNA and Recombinant Protein

The Journal of immunology (1950), 2004-05, Vol.172 (9), p.5561-5569

2004

Volltextzugriff (PDF)

Prevention of Disease Induced by a Partially Heterologous AIDS Virus in Rhesus Monkeys by Using an Adjuvanted Multicomponent Protein Vaccine

Journal of Virology, 2003-01, Vol.77 (2), p.1049-1058

2003

Volltextzugriff (PDF)

Phase 1 safety and immunogenicity trial of malaria vaccine RTS,S/AS02A in adults in a hyperendemic region of western Kenya

The American journal of tropical medicine and hygiene, 2006-07, Vol.75 (1), p.166

2006

Volltextzugriff (PDF)

Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-142 malaria vaccine

Molecular and biochemical parasitology, 2003-05, Vol.128 (2), p.195-204

2003

Volltextzugriff (PDF)

Five year safety and immunogenicity of GlaxoSmithKline's candidate malaria vaccine RTS,S/AS02 following administration to semi-immune adult men living in a malaria-endemic region of The Gambia

Human vaccines, 2009-04, Vol.5 (4), p.242-247

2009

Volltextzugriff (PDF)

Protection against Development of Otitis Media Induced by Nontypeable Haemophilus influenzae by Both Active and Passive Immunization in a Chinchilla Model of Virus-Bacterium Superinfection

Infection and Immunity, 1999-06, Vol.67 (6), p.2746-2762

1999

Volltextzugriff (PDF)

Development of the RTS,S/AS malaria candidate vaccine

Vaccine, 2009-12, Vol.27, p.G67-G71

2009

Volltextzugriff (PDF)

Early Gamma Interferon and Interleukin-2 Responses to Vaccination Predict the Late Resting Memory in Malaria-Naïve and Malaria-Exposed Individuals

Infection and Immunity, 2006-11, Vol.74 (11), p.6331-6338

2006

Volltextzugriff (PDF)

Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study

The Journal of infectious diseases, 2016-09, Vol.214 (5), p.762-771

2016

Volltextzugriff (PDF)

Randomized, Double-Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria-Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection

The Journal of infectious diseases, 2009-08, Vol.200 (3), p.337-346

2009

Volltextzugriff (PDF)

Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine

The Journal of immunology (1950), 2012-05, Vol.188 (10), p.5054-5062

2012

Volltextzugriff (PDF)

A Randomized, Controlled Dose-Finding Phase II Study of the M72/AS01 Candidate Tuberculosis Vaccine in Healthy PPD-Positive Adults

Journal of clinical immunology, 2013-11, Vol.33 (8), p.1360-1375

2013

Volltextzugriff (PDF)

1 – 25 von 483

Suche als RSS-Feed

Aktive Filter

ThemaVaccines

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(374)
Mit Volltextzugriff
(427)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(245)
Life Sciences & Biomedicine
(221)
Humans
(187)
Female
(99)
Male
(95)
Biological And Medical Sciences
(78)
Medical Sciences
(67)
Adult
(58)
Middle Aged
(58)
Infectious Diseases
(47)
Animals
(44)
Immunology
(44)
Malaria
(40)
Microbiology
(40)
Malaria Vaccines - Immunology
(38)
Aged
(32)
Fundamental And Applied Biological Sciences. Psychology
(32)
Life Sciences
(32)
Plasmodium Falciparum - Immunology
(28)
Plasmodium Falciparum
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Does A Kinematically Aligned Total Knee Arthroplasty Restore Function Without Failure Regardless of Alignment Category?

Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5–17 months in Kenya and Tanzania: a randomised controlled trial

Molecular Basis of Allele-Specific Efficacy of a Blood-Stage Malaria Vaccine: Vaccine Development Implications

Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial

Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-γ/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection

Update on the clinical development of candidate malaria vaccines

Malaria vaccine development: Trials, tribulations and reasons for hope

Induction of Plasmodium falciparum-specific CD4+ T cells and memory B cells in Gabonese children vaccinated with RTS,S/AS01(E) and RTS,S/AS02(D)

Evaluation of the Safety and Immunogenicity of Two Antigen Concentrations of the Mtb72F/AS02A Candidate Tuberculosis Vaccine in Purified Protein Derivative-Negative Adults

T cell responses to the RTS,S/AS01(E) and RTS,S/AS02(D) malaria candidate vaccines administered according to different schedules to Ghanaian children

Priming with an Adenovirus 35-Circumsporozoite Protein (CS) Vaccine followed by RTS,S/AS01B Boosting Significantly Improves Immunogenicity to Plasmodium falciparum CS Compared to That with Either Malaria Vaccine Alone

Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research

Induction in Humans of CD8+ and CD4+ T Cell and Antibody Responses by Sequential Immunization with Malaria DNA and Recombinant Protein

Prevention of Disease Induced by a Partially Heterologous AIDS Virus in Rhesus Monkeys by Using an Adjuvanted Multicomponent Protein Vaccine

Phase 1 safety and immunogenicity trial of malaria vaccine RTS,S/AS02A in adults in a hyperendemic region of western Kenya

Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-142 malaria vaccine

Five year safety and immunogenicity of GlaxoSmithKline's candidate malaria vaccine RTS,S/AS02 following administration to semi-immune adult men living in a malaria-endemic region of The Gambia

Protection against Development of Otitis Media Induced by Nontypeable Haemophilus influenzae by Both Active and Passive Immunization in a Chinchilla Model of Virus-Bacterium Superinfection

Development of the RTS,S/AS malaria candidate vaccine

Early Gamma Interferon and Interleukin-2 Responses to Vaccination Predict the Late Resting Memory in Malaria-Naïve and Malaria-Exposed Individuals

Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study

Randomized, Double-Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria-Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection

Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine

A Randomized, Controlled Dose-Finding Phase II Study of the M72/AS01 Candidate Tuberculosis Vaccine in Healthy PPD-Positive Adults

Aktive Filter

Suchergebnisse filtern